Puma pharmaceuticals top
Puma pharmaceuticals top
Puma pharmaceuticals top
Puma pharmaceuticals top
Puma pharmaceuticals top
Puma pharmaceuticals top

Puma pharmaceuticals top

Puma pharmaceuticals top, Puma Biotechnology Announces Initiation of ALISCA Breast1 Phase II Trial of Alisertib in Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer Business Wire top

$39.00

SKU: 7523819

Colour
  • Puma Biotechnology Biotechnology The Pharmaletter The Pharmaletter
  • Puma Biotech anti HER2 breast cancer drug approved in China BioTuesdays
  • 17KB 2001 null null null null null 6 3 2003 null ebOAjueLvpShIM
  • Puma Biotechnology Crunchbase Company Profile Funding
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus